Suspension of trading
Body and Mind Inc. Stock Canadian Securities Exchange
Stocks
BAMM
US09689V1008
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| - CAD | -.--% |
|
-.--% | - |
| Market Cap | 4.65M 4.09M 3.8M 3.49M 6.55M 450M 6.67M 45.44M 17.72M 220M 17.46M 17.08M 762M | P/E 2022 |
-0.39x | P/E 2023 | -0.52x |
|---|---|---|---|---|---|
| Enterprise Value | 23.03M 20.26M 18.82M 17.31M 32.46M 2.23B 33.04M 225M 87.78M 1.09B 86.48M 84.61M 3.77B | EV / Sales 2022 |
0.73x | EV / Sales 2023 | 1.33x |
| Free-Float |
86.65% | Yield 2022 * |
-
| Yield 2023 | - |
| 3 years | 0 | 0.16 | |
| 5 years | 0 | 0.74 | |
| 10 years | 0 | 3.71 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Mills
CEO | Chief Executive Officer | 57 | 2019-08-20 |
Dong Shim
DFI | Director of Finance/CFO | 43 | 2019-08-21 |
Stephen Hoffman
COO | Chief Operating Officer | 61 | 2018-11-14 |
| Director | Title | Age | Since |
|---|---|---|---|
Michael Mills
BRD | Director/Board Member | 57 | 2020-01-22 |
Stephen Hoffman
BRD | Director/Board Member | 61 | 2020-02-29 |
Brent Reuter
BRD | Director/Board Member | 57 | 2019-10-15 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | -.--% | - | - | 29.8K | ||
| -0.10% | -0.79% | -8.54% | -3.35% | 13.64B | ||
| -0.65% | -4.12% | -28.73% | -50.29% | 5.26B | ||
| -0.31% | -0.23% | +0.57% | -1.00% | 4.85B | ||
| -1.74% | -2.53% | +7.97% | -30.00% | 4.25B | ||
| -0.45% | -3.65% | +3.42% | -7.77% | 3.75B | ||
| -1.64% | +2.93% | -2.10% | -1.75% | 3.74B | ||
| -0.31% | +0.13% | -1.42% | +12.88% | 3.53B | ||
| -1.25% | -2.29% | -11.58% | -21.43% | 2.49B | ||
| +0.85% | -1.91% | -3.29% | +49.54% | 1.86B | ||
| Average | -0.56% | +1.42% | -4.86% | -5.91% | 4.82B | |
| Weighted average by Cap. | -0.56% | +1.18% | -6.14% | -9.08% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 31.64M 27.83M 25.85M 23.77M 44.59M 3.06B 45.38M 309M 121M 1.49B 119M 116M 5.18B | 22.82M 20.07M 18.65M 17.15M 32.16M 2.21B 32.74M 223M 86.96M 1.08B 85.67M 83.82M 3.74B |
| Net income | -28.68M -25.22M -23.43M -21.55M -40.41M -2.78B -41.14M -280M -109M -1.35B -108M -105M -4.7B | -20.78M -18.28M -16.98M -15.62M -29.29M -2.01B -29.81M -203M -79.2M -982M -78.02M -76.34M -3.41B |
| Net Debt | 11.67M 10.26M 9.54M 8.77M 16.45M 1.13B 16.74M 114M 44.48M 551M 43.82M 42.87M 1.91B | 18.38M 16.17M 15.02M 13.81M 25.91M 1.78B 26.37M 180M 70.06M 868M 69.02M 67.52M 3.01B |
Employees
142
Sector
Pharmaceuticals
- Stock Market
- Stocks
- BMMJ Stock
- BAMM Stock
Select your edition
All financial news and data tailored to specific country editions
















